![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SCARA3 | Human | 1,2-dichloroethane | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SCARA3 mRNA | CTD | PMID:28960355 | SCARA3 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SCARA3 mRNA | CTD | PMID:30723492 | SCARA3 | Human | 17beta-estradiol | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | Estradiol results in increased expression of SCARA3 mRNA | CTD | PMID:19484750 | SCARA3 | Human | 17beta-estradiol | multiple interactions | ISO | Scara3 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCARA3 mRNA | CTD | PMID:32741896 | SCARA3 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Scara3 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCARA3 mRNA | CTD | PMID:32741896 | SCARA3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SCARA3 mRNA | CTD | PMID:26290441 | SCARA3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SCARA3 mRNA | CTD | PMID:29704546 | SCARA3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of SCARA3 mRNA | CTD | PMID:29704546 | SCARA3 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Scara3 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | SCARA3 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of SCARA3 mRNA | CTD | PMID:37199045 | SCARA3 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SCARA3 mRNA | CTD | PMID:20188158 | SCARA3 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SCARA3 mRNA | CTD | PMID:28628672 | SCARA3 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | bisphenol S results in increased expression of SCARA3 mRNA | CTD | PMID:30951980 | SCARA3 | Human | 5-aza-2'-deoxycytidine | decreases methylation | EXP | | 6480464 | Decitabine results in decreased methylation of SCARA3 promoter | CTD | PMID:18676679 | SCARA3 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of SCARA3 mRNA | CTD | PMID:24780913 | SCARA3 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SCARA3 mRNA | CTD | PMID:32763439 | SCARA3 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SCARA3 gene | CTD | PMID:27153756 | SCARA3 | Human | amphetamine | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of SCARA3 mRNA | CTD | PMID:30779732 | SCARA3 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SCARA3 mRNA | CTD | PMID:26705709 | SCARA3 | Human | avobenzone | increases expression | EXP | | 6480464 | avobenzone results in increased expression of SCARA3 mRNA | CTD | PMID:31016361 | SCARA3 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SCARA3 mRNA | CTD | PMID:26238291 | SCARA3 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SCARA3 mRNA | CTD | PMID:32234424 | SCARA3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SCARA3 intron | CTD | PMID:30157460 | SCARA3 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | SCARA3 | Human | bisphenol A | affects expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SCARA3 mRNA | CTD | PMID:25181051 | SCARA3 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SCARA3 mRNA | CTD | PMID:29718440 | SCARA3 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SCARA3 mRNA | CTD | PMID:30903817 | SCARA3 | Human | bisphenol A | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SCARA3 mRNA | CTD | PMID:30951980 and PMID:34585602 | SCARA3 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SCARA3 mRNA | CTD | PMID:28628672 | SCARA3 | Human | bisphenol F | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | bisphenol F results in increased expression of SCARA3 mRNA | CTD | PMID:30951980 | SCARA3 | Human | bisphenol F | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SCARA3 mRNA | CTD | PMID:38685157 | SCARA3 | Human | buta-1,3-diene | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of SCARA3 mRNA | CTD | PMID:29038090 | SCARA3 | Human | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SCARA3 mRNA | CTD | PMID:29432896 | SCARA3 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of SCARA3 mRNA | CTD | PMID:26079696 | SCARA3 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SCARA3 mRNA | CTD | PMID:38382870 | SCARA3 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SCARA3 mRNA | CTD | PMID:21592394 | SCARA3 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SCARA3 mRNA | CTD | PMID:21592394 | SCARA3 | Human | cerium trichloride | decreases expression | EXP | | 6480464 | cerous chloride results in decreased expression of SCARA3 mRNA | CTD | PMID:28954213 | SCARA3 | Human | choline | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA3 mRNA | CTD | PMID:20938992 | SCARA3 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of SCARA3 mRNA | CTD | PMID:27392435 | SCARA3 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SCARA3 mRNA | CTD | PMID:19320972 and PMID:19376846 | SCARA3 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SCARA3 mRNA | CTD | PMID:20971185 | SCARA3 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SCARA3 mRNA | CTD | PMID:20971185 | SCARA3 | Human | Cuprizon | decreases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of SCARA3 mRNA | CTD | PMID:26577399 and PMID:27523638 | SCARA3 | Human | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of SCARA3 mRNA | CTD | PMID:25047013 | SCARA3 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SCARA3 mRNA | CTD | PMID:28628672 | SCARA3 | Human | diallyl trisulfide | decreases expression | EXP | | 6480464 | diallyl trisulfide results in decreased expression of SCARA3 mRNA | CTD | PMID:34995734 | SCARA3 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of SCARA3 mRNA | CTD | PMID:26705709 | SCARA3 | Human | disodium selenite | decreases methylation | EXP | | 6480464 | Sodium Selenite results in decreased methylation of SCARA3 promoter | CTD | PMID:18676679 | SCARA3 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of SCARA3 mRNA | CTD | PMID:18676679 | SCARA3 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SCARA3 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of SCARA3 mRNA | CTD | PMID:27188386 | SCARA3 | Human | epoxiconazole | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SCARA3 mRNA | CTD | PMID:35436446 | SCARA3 | Human | ethanol | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | Ethanol results in increased expression of SCARA3 mRNA | CTD | PMID:30319688 | SCARA3 | Human | ethanol | affects splicing | ISO | Scara3 (Mus musculus) | 6480464 | Ethanol affects the splicing of SCARA3 mRNA | CTD | PMID:30319688 | SCARA3 | Human | fipronil | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of SCARA3 mRNA | CTD | PMID:34044035 | SCARA3 | Human | folic acid | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA3 mRNA | CTD | PMID:20938992 | SCARA3 | Human | furan | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | furan results in increased expression of SCARA3 mRNA | CTD | PMID:27387713 | SCARA3 | Human | glycidol | decreases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of SCARA3 mRNA | CTD | PMID:24915197 | SCARA3 | Human | glycidol | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | glycidol results in increased expression of SCARA3 mRNA | CTD | PMID:24395379 | SCARA3 | Human | hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of SCARA3 mRNA | CTD | PMID:31256213 | SCARA3 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SCARA3 mRNA | CTD | PMID:28628672 | SCARA3 | Human | inulin | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SCARA3 mRNA | CTD | PMID:36331819 | SCARA3 | Human | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SCARA3 mRNA | CTD | PMID:29432896 | SCARA3 | Human | ketamine | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of SCARA3 mRNA | CTD | PMID:20080153 | SCARA3 | Human | L-methionine | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA3 mRNA | CTD | PMID:20938992 | SCARA3 | Human | lanthanum trichloride | increases expression | EXP | | 6480464 | lanthanum chloride results in increased expression of SCARA3 mRNA | CTD | PMID:28954213 | SCARA3 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SCARA3 mRNA | CTD | PMID:28001369 | SCARA3 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of SCARA3 mRNA | CTD | PMID:29581082 | SCARA3 | Human | microcystin-LR | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of SCARA3 mRNA | CTD | PMID:37342990 | SCARA3 | Human | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of SCARA3 mRNA | CTD | PMID:23360888 | SCARA3 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of SCARA3 mRNA | CTD | PMID:24535843 | SCARA3 | Human | paracetamol | affects expression | ISO | Scara3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SCARA3 mRNA | CTD | PMID:17562736 | SCARA3 | Human | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of SCARA3 mRNA | CTD | PMID:23315990 | SCARA3 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SCARA3 mRNA | CTD | PMID:37995155 | SCARA3 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of SCARA3 mRNA | CTD | PMID:32588087 | SCARA3 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SCARA3 mRNA | CTD | PMID:36331819 | SCARA3 | Human | phenobarbital | multiple interactions | ISO | Scara3 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of SCARA3 mRNA | CTD | PMID:24535843 | SCARA3 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCARA3 mRNA | CTD | PMID:27188386 | SCARA3 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SCARA3 mRNA | CTD | PMID:19710929 | SCARA3 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of SCARA3 mRNA | CTD | PMID:20596804 | SCARA3 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SCARA3 | Human | silicon dioxide | decreases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in decreased expression of SCARA3 mRNA | CTD | PMID:22431001 | SCARA3 | Human | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of SCARA3 mRNA | CTD | PMID:28959546 | SCARA3 | Human | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of SCARA3 mRNA | CTD | PMID:28959546 | SCARA3 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SCARA3 mRNA | CTD | PMID:38568856 | SCARA3 | Human | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of SCARA3 mRNA | CTD | PMID:34032870 | SCARA3 | Human | Soman | increases expression | ISO | Scara3 (Rattus norvegicus) | 6480464 | Soman results in increased expression of SCARA3 mRNA | CTD | PMID:19281266 | SCARA3 | Human | sulforaphane | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | sulforaphane results in increased expression of SCARA3 mRNA | CTD | PMID:30529165 | SCARA3 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of SCARA3 mRNA | CTD | PMID:31758290 | SCARA3 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SCARA3 mRNA | CTD | PMID:21592394 | SCARA3 | Human | testosterone | multiple interactions | ISO | Scara3 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCARA3 mRNA | CTD | PMID:32741896 | SCARA3 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of SCARA3 mRNA | CTD | PMID:21592394 | SCARA3 | Human | thapsigargin | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of SCARA3 protein | CTD | PMID:24648495 | SCARA3 | Human | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of SCARA3 mRNA | CTD | PMID:19442820 | SCARA3 | Human | titanium dioxide | decreases expression | ISO | Scara3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SCARA3 mRNA | CTD | PMID:23557971 | SCARA3 | Human | titanium dioxide | decreases methylation | ISO | Scara3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SCARA3 promoter | CTD | PMID:35295148 | SCARA3 | Human | troglitazone | increases expression | ISO | Scara3 (Mus musculus) | 6480464 | troglitazone results in increased expression of SCARA3 mRNA | CTD | PMID:28973697 | SCARA3 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SCARA3 mRNA | CTD | PMID:28818685 | SCARA3 | Human | valproic acid | affects expression | ISO | Scara3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SCARA3 mRNA | CTD | PMID:17963808 | SCARA3 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCARA3 mRNA | CTD | PMID:27188386 | SCARA3 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SCARA3 mRNA | CTD | PMID:23179753 more ... | SCARA3 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SCARA3 gene | CTD | PMID:29154799 | SCARA3 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SCARA3 mRNA | CTD | PMID:25979313 | SCARA3 | Human | zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of SCARA3 mRNA | CTD | PMID:16870260 | SCARA3 | Human | zinc dichloride | decreases expression | EXP | | 6480464 | zinc chloride results in decreased expression of SCARA3 mRNA | CTD | PMID:16870260 | SCARA3 | Human | zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of SCARA3 mRNA | CTD | PMID:16870260 | |